| Age-related clonal hematopoiesis associated with adverse outcomes S Jaiswal, P Fontanillas, J Flannick, A Manning, PV Grauman, BG Mar, ... New England Journal of Medicine 371 (26), 2488-2498, 2014 | 3592 | 2014 |
| Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning MA Shipp, KN Ross, P Tamayo, AP Weng, JL Kutok, RCT Aguiar, ... Nature medicine 8 (1), 68-74, 2002 | 3055 | 2002 |
| An immunogenic personal neoantigen vaccine for patients with melanoma PA Ott, Z Hu, DB Keskin, SA Shukla, J Sun, DJ Bozym, W Zhang, A Luoma, ... Nature 547 (7662), 217-221, 2017 | 2138 | 2017 |
| Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl E Weisberg, PW Manley, W Breitenstein, J Brüggen, SW Cowan-Jacob, ... Cancer cell 7 (2), 129-141, 2005 | 1847 | 2005 |
| Clinical effect of point mutations in myelodysplastic syndromes R Bejar, K Stevenson, O Abdel-Wahab, N Galili, B Nilsson, ... New England Journal of Medicine 364 (26), 2496-2506, 2011 | 1762 | 2011 |
| Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease S Jaiswal, P Natarajan, AJ Silver, CJ Gibson, AG Bick, E Shvartz, ... New England Journal of Medicine 377 (2), 111-121, 2017 | 1577 | 2017 |
| Evolution and impact of subclonal mutations in chronic lymphocytic leukemia DA Landau, SL Carter, P Stojanov, A McKenna, K Stevenson, ... Cell 152 (4), 714-726, 2013 | 1511 | 2013 |
| SF3B1 and other novel cancer genes in chronic lymphocytic leukemia L Wang, MS Lawrence, Y Wan, P Stojanov, C Sougnez, K Stevenson, ... New England Journal of Medicine 365 (26), 2497-2506, 2011 | 1306 | 2011 |
| Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia AA Ferrando, DS Neuberg, J Staunton, ML Loh, C Huard, SC Raimondi, ... Cancer cell 1 (1), 75-87, 2002 | 1268 | 2002 |
| Integrative analysis reveals selective 9p24. 1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and … MR Green, S Monti, SJ Rodig, P Juszczynski, T Currie, E O'Donnell, ... Blood, The Journal of the American Society of Hematology 116 (17), 3268-3277, 2010 | 1253 | 2010 |
| ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia LZ Rassenti, L Huynh, TL Toy, L Chen, MJ Keating, JG Gribben, ... New England Journal of Medicine 351 (9), 893-901, 2004 | 1155 | 2004 |
| Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes B Chapuy, C Stewart, AJ Dunford, J Kim, A Kamburov, RA Redd, ... Nature medicine 24 (5), 679-690, 2018 | 1118 | 2018 |
| Mutations driving CLL and their evolution in progression and relapse DA Landau, E Tausch, AN Taylor-Weiner, C Stewart, JG Reiter, J Bahlo, ... Nature 526 (7574), 525-530, 2015 | 997 | 2015 |
| NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth T Palomero, WK Lim, DT Odom, ML Sulis, PJ Real, A Margolin, ... Proceedings of the National Academy of Sciences 103 (48), 18261-18266, 2006 | 976 | 2006 |
| The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma KJ Savage, S Monti, JL Kutok, G Cattoretti, D Neuberg, L De Leval, ... Blood 102 (12), 3871-3879, 2003 | 975 | 2003 |
| Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response S Monti, KJ Savage, JL Kutok, F Feuerhake, P Kurtin, M Mihm, B Wu, ... Blood 105 (5), 1851-1861, 2005 | 917 | 2005 |
| Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer S Bullman, CS Pedamallu, E Sicinska, TE Clancy, X Zhang, D Cai, ... Science 358 (6369), 1443-1448, 2017 | 905 | 2017 |
| Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial DB Keskin, AJ Anandappa, J Sun, I Tirosh, ND Mathewson, S Li, ... Nature 565 (7738), 234-239, 2019 | 896 | 2019 |
| Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193) GW Sledge, D Neuberg, P Bernardo, JN Ingle, S Martino, EK Rowinsky, ... Journal of Clinical Oncology 21 (4), 588-592, 2003 | 891 | 2003 |
| Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma JG Gribben, AS Freedman, D Neuberg, DC Roy, KW Blake, SD Woo, ... New England Journal of Medicine 325 (22), 1525-1533, 1991 | 877 | 1991 |
